Found: 83
Select item for more details and to access through your institution.
Specific pattern of p53 phosphorylation during nitric oxide-induced cell cycle arrest.
- Published in:
- Oncogene, 2000, v. 19, n. 54, p. 6369, doi. 10.1038/sj.onc.1204100
- By:
- Publication type:
- Article
Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence.
- Published in:
- Oncogene, 1997, v. 15, n. 25, p. 3007, doi. 10.1038/sj.onc.1201723
- By:
- Publication type:
- Article
Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.
- Published in:
- FASEB Journal, 2022, v. 36, n. 9, p. 1, doi. 10.1096/fj.202200061RR
- By:
- Publication type:
- Article
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Role of genomic instability and p53 in AID-induced c-myc–Igh translocations.
- Published in:
- Nature, 2006, v. 440, n. 7080, p. 105, doi. 10.1038/nature04495
- By:
- Publication type:
- Article
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
- Published in:
- Nature, 2005, v. 436, n. 7052, p. 807, doi. 10.1038/nature03845
- By:
- Publication type:
- Article
A microRNA polycistron as a potential human oncogene.
- Published in:
- Nature, 2005, v. 435, n. 7043, p. 828, doi. 10.1038/nature03552
- By:
- Publication type:
- Article
Intrinsic tumour suppression.
- Published in:
- Nature, 2004, v. 432, n. 7015, p. 307, doi. 10.1038/nature03098
- By:
- Publication type:
- Article
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.
- Published in:
- Nature, 2004, v. 430, n. 7001, p. 797, doi. 10.1038/nature02820
- By:
- Publication type:
- Article
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.
- Published in:
- Nature, 2004, v. 428, n. 6980, p. 332, doi. 10.1038/nature02369
- By:
- Publication type:
- Article
The price of tumour suppression?
- Published in:
- Nature, 2002, v. 415, n. 6867, p. 26, doi. 10.1038/415026a
- By:
- Publication type:
- Article
Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia.
- Published in:
- BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-58
- By:
- Publication type:
- Article
Apoptosis in cancer.
- Published in:
- Carcinogenesis, 2000, v. 21, n. 3, p. 485, doi. 10.1093/carcin/21.3.485
- By:
- Publication type:
- Article
A tumour suppressor network relying on the polyamine-hypusine axis.
- Published in:
- Nature, 2012, v. 487, n. 7406, p. 244, doi. 10.1038/nature11126
- By:
- Publication type:
- Article
The microcosmos of cancer.
- Published in:
- Nature, 2012, v. 482, n. 7385, p. 347, doi. 10.1038/nature10888
- By:
- Publication type:
- Article
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
- Published in:
- Nature, 2011, v. 478, n. 7370, p. 524, doi. 10.1038/nature10334
- By:
- Publication type:
- Article
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
- Published in:
- 2011
- By:
- Publication type:
- Correction notice
HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase.
- Published in:
- Nature, 2010, v. 465, n. 7298, p. 577, doi. 10.1038/nature09141
- By:
- Publication type:
- Article
Stem cells: The promises and perils of p53.
- Published in:
- Nature, 2009, v. 460, n. 7259, p. 1085, doi. 10.1038/4601085a
- By:
- Publication type:
- Article
A microRNA component of the p53 tumour suppressor network.
- Published in:
- Nature, 2007, v. 447, n. 7148, p. 1130, doi. 10.1038/nature05939
- By:
- Publication type:
- Article
Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.
- Published in:
- Oncogene, 2005, v. 24, n. 26, p. 4174, doi. 10.1038/sj.onc.1208600
- By:
- Publication type:
- Article
Control of apoptosis by p53.
- Published in:
- Oncogene, 2003, v. 22, n. 56, p. 9030, doi. 10.1038/sj.onc.1207116
- By:
- Publication type:
- Article
Apoptosis and melanoma chemoresistance.
- Published in:
- Oncogene, 2003, v. 22, n. 20, p. 3138, doi. 10.1038/sj.onc.1206454
- By:
- Publication type:
- Article
Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis.
- Published in:
- Nature Genetics, 2015, v. 47, n. 5, p. 539, doi. 10.1038/ng.3251
- By:
- Publication type:
- Article
Tissue-specific and reversible RNA interference in transgenic mice.
- Published in:
- Nature Genetics, 2007, v. 39, n. 7, p. 914, doi. 10.1038/ng2045
- By:
- Publication type:
- Article
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.
- Published in:
- Nature Genetics, 2005, v. 37, n. 11, p. 1289, doi. 10.1038/ng1651
- By:
- Publication type:
- Article
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.
- Published in:
- Nature Genetics, 2003, v. 33, n. 3, p. 396, doi. 10.1038/ng1091
- By:
- Publication type:
- Article
Gene Mutations and Genomic Rearrangements in the Mouse as a Result of Transposon Mobilization from Chromosomal Concatemers.
- Published in:
- PLoS Genetics, 2006, v. 3, n. 3, p. e156, doi. 10.1371/journal.pgen.0020156
- By:
- Publication type:
- Article
The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
- Published in:
- Nature Structural & Molecular Biology, 2007, v. 14, n. 3, p. 185, doi. 10.1038/nsmb1209
- By:
- Publication type:
- Article
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.17929
- By:
- Publication type:
- Article
Engineering megabase-sized genomic deletions with MACHETE (Molecular Alteration of Chromosomes with Engineered Tandem Elements).
- Published in:
- Nature Protocols, 2024, v. 19, n. 5, p. 1381, doi. 10.1038/s41596-024-00953-9
- By:
- Publication type:
- Article
Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 6, p. 577, doi. 10.1038/nbt.3837
- By:
- Publication type:
- Article
Prediction of potent shRNAs with a sequential classification algorithm.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 4, p. 350, doi. 10.1038/nbt.3807
- By:
- Publication type:
- Article
Inducible in vivo genome editing with CRISPR-Cas9.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 4, p. 390, doi. 10.1038/nbt.3155
- By:
- Publication type:
- Article
Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 1, p. 79, doi. 10.1038/nbt.1720
- By:
- Publication type:
- Article
Towards patient-based cancer therapeutics.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 3, p. 264, doi. 10.1038/nbt.1526
- By:
- Publication type:
- Article
scKINETICS: inference of regulatory velocity with single-cell transcriptomics data.
- Published in:
- Bioinformatics, 2023, v. 39, p. i394, doi. 10.1093/bioinformatics/btad267
- By:
- Publication type:
- Article
Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression <i>In Vivo</i> by Inducible RNA Interference.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101263
- By:
- Publication type:
- Article
Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095236
- By:
- Publication type:
- Article
Two Distinct Categories of Focal Deletions in Cancer Genomes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066264
- By:
- Publication type:
- Article
Variability of Inducible Expression across the Hematopoietic System of Tetracycline Transactivator Transgenic Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054009
- By:
- Publication type:
- Article
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.
- Published in:
- Nature Genetics, 2002, v. 31, n. 2, p. 133, doi. 10.1038/ng888
- By:
- Publication type:
- Article
p53 and p73: seeing double?
- Published in:
- Nature Genetics, 2000, v. 26, n. 4, p. 391, doi. 10.1038/82497
- By:
- Publication type:
- Article
Cancer: Mutant p53 and chromatin regulation.
- Published in:
- Nature, 2015, v. 525, n. 7568, p. 199, doi. 10.1038/nature15212
- By:
- Publication type:
- Article
Corrigendum: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system.
- Published in:
- 2015
- By:
- Publication type:
- Correction Notice
Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.
- Published in:
- Nature, 2015, v. 518, n. 7538, p. 240, doi. 10.1038/nature13948
- By:
- Publication type:
- Article
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system.
- Published in:
- Nature, 2014, v. 516, n. 7531, p. 423, doi. 10.1038/nature13902
- By:
- Publication type:
- Article
PTEN action in leukaemia dictated by the tissue microenvironment.
- Published in:
- Nature, 2014, v. 510, n. 7505, p. 402, doi. 10.1038/nature13239
- By:
- Publication type:
- Article
Non-germline genetically engineered mouse models for translational cancer research.
- Published in:
- 2010
- By:
- Publication type:
- journal article